🇺🇸 FDA
Pipeline program

Solriamfetol 75 MG

850945

Approved small_molecule completed

Quick answer

Solriamfetol 75 MG for Insomnia is a Approved program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Axsome Therapeutics
Indication
Insomnia
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials